Lineage Cell Therapeutics, Inc. (LCTX)
USD 0.5
(0.93%)
USD 0.5
(0.93%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.12 USD | 25.0% |
| 2022 | -0.16 USD | 30.43% |
| 2021 | -0.23 USD | -64.29% |
| 2020 | -0.14 USD | -72.2% |
| 2019 | -0.08 USD | 77.42% |
| 2018 | -0.36 USD | -111.76% |
| 2017 | -0.17 USD | -148.57% |
| 2016 | 0.35 USD | 159.32% |
| 2015 | -0.59 USD | -7.27% |
| 2014 | -0.55 USD | 32.1% |
| 2013 | -0.81 USD | -84.09% |
| 2012 | -0.44 USD | -25.71% |
| 2011 | -0.35 USD | -25.0% |
| 2010 | -0.28 USD | -55.56% |
| 2009 | -0.18 USD | -12.5% |
| 2008 | -0.16 USD | -154.37% |
| 2007 | -0.06 USD | 23.94% |
| 2006 | -0.08 USD | 31.08% |
| 2005 | -0.12 USD | 33.33% |
| 2004 | -0.18 USD | -50.0% |
| 2003 | -0.12 USD | 47.83% |
| 2002 | -0.23 USD | 28.13% |
| 2001 | -0.32 USD | 28.89% |
| 2000 | -0.45 USD | 11.76% |
| 1999 | -0.51 USD | -142.86% |
| 1998 | -0.21 USD | 38.24% |
| 1997 | -0.34 USD | -30.77% |
| 1996 | -0.26 USD | 13.33% |
| 1995 | -0.30 USD | -20.0% |
| 1994 | -0.25 USD | -8.7% |
| 1993 | -0.23 USD | -27.78% |
| 1992 | -0.18 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.03 USD | 14.8% |
| 2024 Q1 | -0.04 USD | -29.24% |
| 2023 Q1 | -0.03 USD | 33.25% |
| 2023 Q4 | -0.03 USD | 31.94% |
| 2023 Q2 | -0.03 USD | -18.53% |
| 2023 Q3 | -0.04 USD | -32.57% |
| 2023 FY | - USD | 25.0% |
| 2022 FY | - USD | 30.43% |
| 2022 Q3 | -0.04 USD | 38.98% |
| 2022 Q4 | -0.04 USD | -7.78% |
| 2022 Q1 | -0.05 USD | 71.24% |
| 2022 Q2 | -0.06 USD | -20.65% |
| 2021 Q3 | -0.05 USD | -55.67% |
| 2021 FY | - USD | -64.29% |
| 2021 Q4 | -0.17 USD | -264.03% |
| 2021 Q1 | -0.01 USD | -165.93% |
| 2021 Q2 | -0.03 USD | -237.08% |
| 2020 Q3 | -0.05 USD | -18.85% |
| 2020 FY | - USD | -72.2% |
| 2020 Q1 | -0.06 USD | -86.38% |
| 2020 Q4 | 0.01 USD | 126.11% |
| 2020 Q2 | -0.04 USD | 22.46% |
| 2019 Q1 | 0.30 USD | 185.71% |
| 2019 Q3 | -0.11 USD | 45.0% |
| 2019 Q4 | -0.03 USD | 72.64% |
| 2019 FY | - USD | 77.42% |
| 2019 Q2 | -0.20 USD | -166.67% |
| 2018 Q3 | 0.53 USD | 1696.39% |
| 2018 FY | - USD | -111.76% |
| 2018 Q1 | -0.50 USD | 13.79% |
| 2018 Q4 | -0.35 USD | -166.04% |
| 2018 Q2 | -0.03 USD | 93.36% |
| 2017 Q1 | 0.46 USD | 1031.17% |
| 2017 FY | - USD | -148.57% |
| 2017 Q4 | -0.58 USD | -583.33% |
| 2017 Q2 | -0.11 USD | -123.91% |
| 2017 Q3 | 0.12 USD | 209.09% |
| 2016 Q4 | -0.05 USD | -116.47% |
| 2016 Q1 | -0.19 USD | -26.67% |
| 2016 Q2 | 0.26 USD | 236.84% |
| 2016 Q3 | 0.30 USD | 15.38% |
| 2016 FY | - USD | 159.32% |
| 2015 Q1 | -0.13 USD | 7.14% |
| 2015 Q2 | -0.12 USD | 7.69% |
| 2015 Q4 | -0.15 USD | 16.67% |
| 2015 FY | - USD | -7.27% |
| 2015 Q3 | -0.18 USD | -50.0% |
| 2014 Q2 | -0.15 USD | -7.14% |
| 2014 Q3 | -0.12 USD | 20.0% |
| 2014 Q4 | -0.14 USD | -16.67% |
| 2014 Q1 | -0.14 USD | 60.0% |
| 2014 FY | - USD | 32.1% |
| 2013 Q3 | -0.16 USD | -14.29% |
| 2013 Q2 | -0.14 USD | 6.67% |
| 2013 Q1 | -0.15 USD | -25.0% |
| 2013 FY | - USD | -84.09% |
| 2013 Q4 | -0.35 USD | -118.75% |
| 2012 Q2 | -0.11 USD | -10.0% |
| 2012 Q1 | -0.10 USD | 9.09% |
| 2012 FY | - USD | -25.71% |
| 2012 Q3 | -0.10 USD | 9.09% |
| 2012 Q4 | -0.12 USD | -20.0% |
| 2011 Q3 | -0.08 USD | 12.79% |
| 2011 Q1 | -0.07 USD | -10.3% |
| 2011 Q2 | -0.09 USD | -25.86% |
| 2011 Q4 | -0.11 USD | -43.98% |
| 2011 FY | - USD | -25.0% |
| 2010 Q3 | -0.11 USD | -82.72% |
| 2010 Q1 | -0.04 USD | -192.4% |
| 2010 FY | - USD | -55.56% |
| 2010 Q2 | -0.06 USD | -54.76% |
| 2010 Q4 | -0.06 USD | 42.64% |
| 2009 Q1 | -0.06 USD | 5.96% |
| 2009 Q2 | -0.05 USD | 9.5% |
| 2009 Q4 | 0.04 USD | 138.27% |
| 2009 Q3 | -0.11 USD | -102.58% |
| 2009 FY | - USD | -12.5% |
| 2008 Q4 | -0.06 USD | -40.53% |
| 2008 Q1 | -0.02 USD | -45.77% |
| 2008 Q3 | -0.05 USD | -62.14% |
| 2008 Q2 | -0.03 USD | -35.27% |
| 2008 FY | - USD | -154.37% |
| 2007 Q4 | -0.01 USD | -52.69% |
| 2007 Q2 | -0.02 USD | 38.11% |
| 2007 Q1 | -0.02 USD | -45.24% |
| 2007 FY | - USD | 23.94% |
| 2007 Q3 | -0.01 USD | 38.41% |
| 2006 Q2 | -0.03 USD | -38.97% |
| 2006 Q4 | -0.02 USD | -11.26% |
| 2006 Q3 | -0.02 USD | 48.99% |
| 2006 Q1 | -0.02 USD | 2.29% |
| 2006 FY | - USD | 31.08% |
| 2005 FY | - USD | 33.33% |
| 2005 Q1 | -0.04 USD | -32.57% |
| 2005 Q2 | -0.02 USD | 39.07% |
| 2005 Q3 | -0.02 USD | 6.45% |
| 2005 Q4 | -0.02 USD | 6.03% |
| 2004 Q4 | -0.03 USD | -20.87% |
| 2004 Q1 | -0.10 USD | -172.48% |
| 2004 Q2 | -0.02 USD | 75.2% |
| 2004 Q3 | -0.03 USD | -2.42% |
| 2004 FY | - USD | -50.0% |
| 2003 Q1 | -0.06 USD | 3.15% |
| 2003 FY | - USD | 47.83% |
| 2003 Q3 | 0.03 USD | 154.05% |
| 2003 Q2 | -0.06 USD | -0.18% |
| 2003 Q4 | -0.04 USD | -222.33% |
| 2002 Q3 | -0.05 USD | 30.01% |
| 2002 Q4 | -0.06 USD | -21.44% |
| 2002 FY | - USD | 28.13% |
| 2002 Q1 | -0.06 USD | -13.64% |
| 2002 Q2 | -0.07 USD | -10.69% |
| 2001 Q2 | -0.10 USD | -16.63% |
| 2001 Q1 | -0.08 USD | 9.39% |
| 2001 Q3 | -0.08 USD | 19.32% |
| 2001 FY | - USD | 28.89% |
| 2001 Q4 | -0.05 USD | 31.5% |
| 2000 Q3 | -0.11 USD | 8.33% |
| 2000 FY | - USD | 11.76% |
| 2000 Q1 | -0.12 USD | 14.29% |
| 2000 Q2 | -0.12 USD | 0.0% |
| 2000 Q4 | -0.09 USD | 16.73% |
| 1999 Q2 | -0.09 USD | -12.5% |
| 1999 Q1 | -0.08 USD | 0.0% |
| 1999 FY | - USD | -142.86% |
| 1999 Q4 | -0.14 USD | 33.33% |
| 1999 Q3 | -0.21 USD | -133.33% |
| 1998 Q1 | -0.11 USD | -83.33% |
| 1998 FY | - USD | 38.24% |
| 1998 Q3 | -0.11 USD | -37.5% |
| 1998 Q2 | -0.08 USD | 27.27% |
| 1997 FY | - USD | -30.77% |
| 1997 Q1 | -0.06 USD | 33.33% |
| 1997 Q4 | -0.06 USD | 40.0% |
| 1997 Q3 | -0.10 USD | 0.0% |
| 1997 Q2 | -0.10 USD | -66.67% |
| 1996 Q2 | -0.06 USD | 16.71% |
| 1996 Q3 | -0.09 USD | -54.37% |
| 1996 Q4 | -0.09 USD | 0.0% |
| 1996 FY | - USD | 13.33% |
| 1996 Q1 | -0.07 USD | 0.0% |
| 1995 Q3 | -0.04 USD | 51.04% |
| 1995 Q4 | -0.07 USD | -75.0% |
| 1995 Q2 | -0.08 USD | -16.71% |
| 1995 Q1 | -0.07 USD | 12.5% |
| 1995 FY | - USD | -20.0% |
| 1994 Q1 | -0.05 USD | 37.5% |
| 1994 FY | - USD | -8.7% |
| 1994 Q3 | -0.06 USD | 10.04% |
| 1994 Q2 | -0.07 USD | -33.4% |
| 1994 Q4 | -0.08 USD | -33.33% |
| 1993 Q1 | -0.05 USD | 16.67% |
| 1993 Q3 | -0.06 USD | 20.11% |
| 1993 Q4 | -0.08 USD | -33.33% |
| 1993 FY | - USD | -27.78% |
| 1993 Q2 | -0.08 USD | -50.2% |
| 1992 Q2 | -0.04 USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1992 Q4 | -0.06 USD | -20.0% |
| 1992 Q1 | -0.04 USD | 0.0% |
| 1992 Q3 | -0.05 USD | -25.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -0.60 USD | 80.0% |
| Ampio Pharmaceuticals, Inc. | -10.67 USD | 98.875% |
| Armata Pharmaceuticals, Inc. | -1.91 USD | 93.717% |
| Actinium Pharmaceuticals, Inc. | -1.83 USD | 93.443% |
| Azitra, Inc. | -54.76 USD | 99.781% |
| Can-Fite BioPharma Ltd. | -1.79 USD | 93.296% |
| Chromocell Therapeutics Corporation | -1.28 USD | 90.625% |
| Calidi Biotherapeutics, Inc. | -1.73 USD | 93.064% |
| CEL-SCI Corporation | -0.73 USD | 83.562% |
| iBio, Inc. | -6.50 USD | 98.154% |
| MAIA Biotechnology, Inc. | -1.49 USD | 91.946% |
| Matinas BioPharma Holdings, Inc. | -5.28 USD | 97.727% |
| Navidea Biopharmaceuticals, Inc. | -0.59 USD | 79.661% |
| NovaBay Pharmaceuticals, Inc. | -138.65 USD | 99.913% |
| NanoViricides, Inc. | -0.70 USD | 82.857% |
| Oragenics, Inc. | -9.18 USD | 98.693% |
| BiomX Inc. | -5.10 USD | 97.647% |
| BiomX Inc. | -5.10 USD | 97.647% |
| Protalix BioTherapeutics, Inc. | 0.12 USD | 200.0% |
| Palatin Technologies, Inc. | -2.02 USD | 94.059% |
| Scorpius Holdings, Inc. | -347.20 USD | 99.965% |